Drugs / Biphasic Calcium Phosphate
Biphasic Calcium Phosphate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT06071416 Comparator | Feb → Mar 2024 | paranasal sinus disorder | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT04059458 Background | Oct 2019 → Nov 2023 | periodontal disorder | University of Oslo | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biphasic calcium phosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04059458 ↗ |
| Known as | BCP | “including biphasic calcium phosphate (BCP), as substitutes for autogenous bone” NCT06071416 ↗ |
| Known as | Straumann Bone Ceramic | “Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)” NCT04059458 ↗ |